26 percent of senior oncology patients use alternative therapies
the ONA take:
More than a quarter of senior oncology patients use complementary or alternative medicines (CAM), according to a study published in the Journal of Geriatric Oncology.
"Currently, few oncologists are aware of the alternative medicines their patients take," says Ginah Nightingale, PharmD, an Assistant Professor in the Jefferson College of Pharmacy at Thomas Jefferson University.
"Patients often fail to disclose the CAMs they take because they think they are safe, natural, nontoxic and not relevant to their cancer care, because they think their doctor will disapprove, or because the doctor doesn't specifically ask."
For the study, researchers surveyed senior patients with cancer who came for consultations at the Thomas Jefferson University Hospital Senior Adult Oncology Multi-Disciplinary clinic. Researchers found that 26% of patients were taking CAMs at some point during their cancer care. Of those, 68% were over 80 years of age and the majority of users were women.
The most common CAMs used by patients were alternative therapies for macular degeneration, probiotics, joint health, and mega-dose vitamins or minerals.
The finidngs suggest that it is very important that clinicians comprehensively screen older patients with cancer for all medications used, including CAMs. Certain CAMs like St. John's wort can interact with certain anti-cancer medications, making them less effective.
More than a quarter of senior oncology patients use complementary or alternative medicines (CAM).
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|